Yingmei Zhang, Zhuo Zhang, Jinmei Li, Limin Li, Xueying Han, Lina Han, Longhu Hu, Shuye Wang, Yanhong Zhao, Xiaoxia Li, Ying Zhang, Shengjin Fan, Chengfang Lv, Yinghua Li, Yanhua Su, Hui Zhao, Xin Zhang and Jin Zhou Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia Cancer 119
Article first published online: 28 AUG 2012 | DOI: 10.1002/cncr.27650
This study shows that the single-agent arsenic trioxide regimens have a high antileukemic efficacy and low toxicity, and can be used as first-line treatment for elderly patients with de novo acute promyelocytic leukemia.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field